Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Rainer Müller

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Concepts & Ideas

Chemicals & Drugs

Occupations

Objects

Procedures

Devices

Drug Delivery Systems

Living Beings

Mice

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
20
Souto, Eliana B.
13
Kayser, Oliver
11
Wissing, Sylvia
11
Olbrich, Carsten
10
Mäder, Karsten
9
Lück, M
9
Hahn, Helmut
9
Kresse, Mayk
8
Blunk, T
8
Paulke, Bernd-R
7
Gessner, Andrea
6
Junyaprasert, Varaporn Buraphacheep
6
Liesenfeld, Oliver
6
Göppert, Torsten
6
Tabatt, Kerstin

Sign-in to see all Coauthors

Publications

TOP 3
Muchow M; Schmitz E I; Despatova N; Maincent P; Müller R H
Omega-3 fatty acids-loaded lipid nanoparticles for patient-convenient oral bioavailability enhancement.
Junyaprasert Varaporn B; Teeranachaideekul Veerawat; Souto Eliana B; Boonme Prapaporn; Müller Rainer H
Q10-loaded NLC versus nanoemulsions: stability, rheology and in vitro skin permeation.
Mishra Prabhat R; Al Shaal Loaye; Müller Rainer H; Keck Cornelia M
Production and characterization of Hesperetin nanosuspensions for dermal delivery.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Rainer Müller (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Muchow M; Schmitz E I; Despatova N; Maincent P; Müller R H
Omega-3 fatty acids-loaded lipid nanoparticles for patient-convenient oral bioavailability enhancement.
Die Pharmazie 2009;64(8):499-504.
2009: Junyaprasert Varaporn B; Teeranachaideekul Veerawat; Souto Eliana B; Boonme Prapaporn; Müller Rainer H
Q10-loaded NLC versus nanoemulsions: stability, rheology and in vitro skin permeation.
International journal of pharmaceutics 2009;377(1-2):207-14.
2009: Mishra Prabhat R; Al Shaal Loaye; Müller Rainer H; Keck Cornelia M
Production and characterization of Hesperetin nanosuspensions for dermal delivery.
International journal of pharmaceutics 2009;371(1-2):182-9.
2009: Mauludin Rachmat; Müller Rainer H; Keck Cornelia M
Kinetic solubility and dissolution velocity of rutin nanocrystals.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2009;36(4-5):502-10.
2009: Mauludin Rachmat; Müller Rainer H; Keck Cornelia M
Development of an oral rutin nanocrystal formulation.
International journal of pharmaceutics 2009;370(1-2):202-9.
2009: Joshi Medha D; Müller Rainer H
Lipid nanoparticles for parenteral delivery of actives.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2009;71(2):161-72.
2009: Pardeike Jana; Hommoss Aiman; Müller Rainer H
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.
International journal of pharmaceutics 2009;366(1-2):170-84.
2008: Teeranachaideekul Veerawat; Boonme Prapaporn; Souto Eliana Barbosa; Müller Rainer Helmut; Junyaprasert Varaporn Buraphacheep
Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC.
Journal of controlled release : official journal of the Controlled Release Society 2008;128(2):134-41.
2008: Keck Cornelia M; Müller Rainer H
Size analysis of submicron particles by laser diffractometry--90% of the published measurements are false.
International journal of pharmaceutics 2008;355(1-2):150-63.
2008: Teeranachaideekul Veerawat; Junyaprasert Varaporn B; Souto Eliana B; Müller Rainer H
Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology.
International journal of pharmaceutics 2008;354(1-2):227-34.
2008: Teeranachaideekul Veerawat; Souto Eliana B; Müller Rainer H; Junyaprasert Varaporn B
Physicochemical characterization and in vitro release studies of ascorbyl palmitate-loaded semi-solid nanostructured lipid carriers (NLC gels).
Journal of microencapsulation 2008;25(2):111-20.
2008: Müller R H; Runge S A; Ravelli V; Thünemann A F; Mehnert W; Souto E B
Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporation.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;68(3):535-44.
2008: Junghanns Jens-Uwe A H; Müller Rainer H
Nanocrystal technology, drug delivery and clinical applications.
International journal of nanomedicine 2008;3(3):295-309.
2007: Teeranachaideekul Veerawat; Müller Rainer Helmut; Junyaprasert Varaporn Buraphacheep
Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)--effects of formulation parameters on physicochemical stability.
International journal of pharmaceutics 2007;340(1-2):198-206.
2007: Teeranachaideekul Veerawat; Souto Eliana B; Junyaprasert Varaporn B; Müller Rainer H
Cetyl palmitate-based NLC for topical delivery of Coenzyme Q(10) - development, physicochemical characterization and in vitro release studies.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2007;67(1):141-8.
2007: Souto E B; Müller R H
Rheological and in vitro release behaviour of clotrimazole-containing aqueous SLN dispersions and commercial creams.
Die Pharmazie 2007;62(7):505-9.
2007: Müller R H; Petersen R D; Hommoss A; Pardeike J
Nanostructured lipid carriers (NLC) in cosmetic dermal products.
Advanced drug delivery reviews 2007;59(6):522-30.
2006: Möschwitzer Jan; Müller Rainer H
New method for the effective production of ultrafine drug nanocrystals.
Journal of nanoscience and nanotechnology 2006;6(9-10):3145-53.
2006: Müller R H; Runge S; Ravelli V; Mehnert W; Thünemann A F; Souto E B
Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals.
International journal of pharmaceutics 2006;317(1):82-9.
2006: Souto E B; Mehnert W; Müller R H
Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLC.
Journal of microencapsulation 2006;23(4):417-33.
2006: Souto E B; Müller R H
Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization.
Journal of microencapsulation 2006;23(4):377-88.
2006: Weyhers H; Ehlers S; Hahn H; Souto E B; Müller R H
Solid lipid nanoparticles (SLN)--effects of lipid composition on in vitro degradation and in vivo toxicity.
Die Pharmazie 2006;61(6):539-44.
2006: Souto E B; Müller R H
The use of SLN and NLC as topical particulate carriers for imidazole antifungal agents.
Die Pharmazie 2006;61(5):431-7.
2006: Gessner A; Paulke B R; Müller R H; Göppert T M
Protein rejecting properties of PEG-grafted nanoparticles: influence of PEG-chain length and surface density evaluated by two-dimensional electrophoresis and bicinchoninic acid (BCA)-proteinassay.
Die Pharmazie 2006;61(4):293-7.
2006: Möschwitzer Jan; Müller Rainer H
Spray coated pellets as carrier system for mucoadhesive drug nanocrystals.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2006;62(3):282-7.
2005: Souto E B; Müller R H; Gohla S
A novel approach based on lipid nanoparticles (SLN) for topical delivery of alpha-lipoic acid.
Journal of microencapsulation 2005;22(6):581-92.
2005: Hernández-Trejo Norma; Kayser Oliver; Steckel Hartwig; Müller Rainer H
Characterization of nebulized buparvaquone nanosuspensions--effect of nebulization technology.
Journal of drug targeting 2005;13(8-9):499-507.
2005: Souto E B; Gohla S H; Müller R H
Rheology of nanostructured lipid carriers (NLC) suspended in a viscoelastic medium.
Die Pharmazie 2005;60(9):671-3.
2005: Göppert T M; Müller R H
Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting.
International journal of pharmaceutics 2005;302(1-2):172-86.
2005: Souto E B; Müller R H
SLN and NLC for topical delivery of ketoconazole.
Journal of microencapsulation 2005;22(5):501-10.
2005: Göppert Torsten M; Müller Rainer H
Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN).
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2005;60(3):361-72.
2005: Rank Franziska; Scheuermann Hans-Jörg; Wozniewski Thomas; Müller Rainer Helmut
Managing compliance in production-insights and comparisons in chemical-pharmaceutical companies.
PDA journal of pharmaceutical science and technology / PDA 2005;59(4):233-9.
2005: Zimmermann E; Souto E B; Müller R H
Physicochemical investigations on the structure of drug-free and drug-loaded solid lipid nanoparticles (SLN) by means of DSC and 1H NMR.
Die Pharmazie 2005;60(7):508-13.
2005: Souto E B; Anselmi C; Centini M; Müller R H
Preparation and characterization of n-dodecyl-ferulate-loaded solid lipid nanoparticles (SLN).
International journal of pharmaceutics 2005;295(1-2):261-8.
2005: Göppert Torsten M; Müller Rainer H
Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns.
Journal of drug targeting 2005;13(3):179-87.
2005: Saupe Anne; Wissing Sylvia A; Lenk Andreas; Schmidt Corinna; Müller Rainer H
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) -- structural investigations on two different carrier systems.
Bio-medical materials and engineering 2005;15(5):393-402.
2004: Dunay Ildiko R; Heimesaat Markus M; Bushrab Faris Nadiem; Müller Rainer H; Stocker Hartmut; Arasteh Keikawus; Kurowski Michael; Fitzner Rudolf; Borner Klaus; Liesenfeld Oliver
Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis.
Antimicrobial agents and chemotherapy 2004;48(12):4848-54.
2004: Möschwitzer Jan; Achleitner Georg; Pomper Herbert; Müller Rainer H
Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;58(3):615-9.
2004: Lippacher A; Müller R H; Mäder K
Liquid and semisolid SLN dispersions for topical application: rheological characterization.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;58(3):561-7.
2004: Souto E B; Wissing S A; Barbosa C M; Müller R H
Comparative study between the viscoelastic behaviors of different lipid nanoparticle formulations.
Journal of cosmetic science 2004;55(5):463-71.
2004: Rudolph Carsten; Schillinger Ulrike; Ortiz Aurora; Tabatt Kerstin; Plank Christian; Müller Rainer H; Rosenecker Joseph
Application of novel solid lipid nanoparticle (SLN)-gene vector formulations based on a dimeric HIV-1 TAT-peptide in vitro and in vivo.
Pharmaceutical research 2004;21(9):1662-9.
2004: Olbrich Carsten; Schöler Nadja; Tabatt Kerstin; Kayser Oliver; Müller Rainer Helmut
Cytotoxicity studies of Dynasan 114 solid lipid nanoparticles (SLN) on RAW 264.7 macrophages-impact of phagocytosis on viability and cytokine production.
The Journal of pharmacy and pharmacology 2004;56(7):883-91.
2004: Souto E B; Wissing S A; Barbosa C M; Müller R H
Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;58(1):83-90.
2004: Tabatt Kerstin; Kneuer Carsten; Sameti Mohammad; Olbrich Carsten; Müller Rainer H; Lehr Claus-Michael; Bakowsky Udo
Transfection with different colloidal systems: comparison of solid lipid nanoparticles and liposomes.
Journal of controlled release : official journal of the Controlled Release Society 2004;97(2):321-32.
2004: Souto E B; Wissing S A; Barbosa C M; Müller R H
Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery.
International journal of pharmaceutics 2004;278(1):71-7.
2004: Müller Rainer H; Keck Cornelia M
Drug delivery to the brain--realization by novel drug carriers.
Journal of nanoscience and nanotechnology 2004;4(5):471-83.
2004: Olbrich Carsten; Gessner Andrea; Schröder Werner; Kayser Oliver; Müller Rainer H
Lipid-drug conjugate nanoparticles of the hydrophilic drug diminazene-cytotoxicity testing and mouse serum adsorption.
Journal of controlled release : official journal of the Controlled Release Society 2004;96(3):425-35.
2004: Akkar Aslihan; Namsolleck Pawel; Blaut Michael; Müller Rainer H
Solubilizing poorly soluble antimycotic agents by emulsification via a solvent-free process.
AAPS PharmSciTech 2004;5(1):E24.
2004: Tabatt Kerstin; Sameti Mohammad; Olbrich Carsten; Müller Rainer H; Lehr Claus-Michael
Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transfer.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;57(2):155-62.
2004: Göppert Torsten M; Müller Rainer H
Alternative sample preparation prior to two-dimensional electrophoresis protein analysis on solid lipid nanoparticles.
Electrophoresis 2004;25(1):134-40.
2004: Müller R H; Schmidt S; Buttle I; Akkar A; Schmitt J; Brömer S
SolEmuls-novel technology for the formulation of i.v. emulsions with poorly soluble drugs.
International journal of pharmaceutics 2004;269(2):293-302.
2003: Funke Adrian Peter; Günther Clemens; Müller Rainer Helmut; Lipp Ralph
Development of matrix patches for transdermal delivery of a highly lipophilic antiestrogen.
Drug development and industrial pharmacy 2003;29(7):785-93.
2003: Wissing Sylvia A; Müller Rainer H
The influence of solid lipid nanoparticles on skin hydration and viscoelasticity--in vivo study.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2003;56(1):67-72.
2003: Akkar Aslihan; Müller Rainer H
Intravenous itraconazole emulsions produced by SolEmuls technology.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2003;56(1):29-36.
2003: Gessner Andrea; Lieske Antje; Paulke Bernd-R; Müller Rainer H
Functional groups on polystyrene model nanoparticles: influence on protein adsorption.
Journal of biomedical materials research. Part A 2003;65(3):319-26.
2003: Göppert Torsten M; Müller Rainer H
Plasma protein adsorption of Tween 80- and poloxamer 188-stabilized solid lipid nanoparticles.
Journal of drug targeting 2003;11(4):225-31.
2003: Akkar A; Müller R H
Formulation of intravenous carbamazepine emulsions by SolEmuls technology.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2003;55(3):305-12.
2003: Wissing Sylvia A; Müller Rainer H
Cosmetic applications for solid lipid nanoparticles (SLN).
International journal of pharmaceutics 2003;254(1):65-8.
2003: Schmidt Sven; Müller Rainer H
Plasma protein adsorption patterns on surfaces of Amphotericin B-containing fat emulsions.
International journal of pharmaceutics 2003;254(1):3-5.
2003: Rudolph Carsten; Plank Christian; Lausier James; Schillinger Ulrike; Müller Rainer H; Rosenecker Joseph
Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells.
The Journal of biological chemistry 2003;278(13):11411-8.
2003: Rosenecker J; Naundorf S; Gersting S W; Hauck R W; Gessner A; Nicklaus P; Müller R H; Rudolph C
Interaction of bronchoalveolar lavage fluid with polyplexes and lipoplexes: analysing the role of proteins and glycoproteins.
The journal of gene medicine 2003;5(1):49-60.
2002: Müller R H; Radtke M; Wissing S A
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.
Advanced drug delivery reviews 2002;54 Suppl 1():S131-55.
2002: Olbrich Carsten; Gessner Andrea; Kayser Oliver; Müller Rainer Helmut
Lipid-drug-conjugate (LDC) nanoparticles as novel carrier system for the hydrophilic antitrypanosomal drug diminazenediaceturate.
Journal of drug targeting 2002;10(5):387-96.
2002: Müller R H; Radtke M; Wissing S A
Nanostructured lipid matrices for improved microencapsulation of drugs.
International journal of pharmaceutics 2002;242(1-2):121-8.
2002: Olbrich Carsten; Müller Rainer Helmut; Tabatt Kerstin; Kayser Oliver; Schulze Christoph; Schade Rüdiger
Stable biocompatible adjuvants--a new type of adjuvant based on solid lipid nanoparticles: a study on cytotoxicity, compatibility and efficacy in chicken.
Alternatives to laboratory animals : ATLA 2002;30(4):443-58.
2002: Funke Adrian Peter; Günther Clemens; Müller Rainer Helmut; Lipp Ralph
In-vitro release and transdermal fluxes of a highly lipophilic drug and of enhancers from matrix TDS.
Journal of controlled release : official journal of the Controlled Release Society 2002;82(1):63-70.
2002: Wissing S A; Müller R H
Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration.
Journal of controlled release : official journal of the Controlled Release Society 2002;81(3):225-33.
2002: Lind Kathrin; Kresse Mayk; Debus Nils P; Müller Rainer H
A novel formulation for superparamagnetic iron oxide (SPIO) particles enhancing MR lymphography: comparison of physicochemical properties and the in vivo behaviour.
Journal of drug targeting 2002;10(3):221-30.
2002: Funke Adrian P; Schiller Roman; Motzkus Hans W; Günther Clemens; Müller Rainer H; Lipp Ralph
Transdermal delivery of highly lipophilic drugs: in vitro fluxes of antiestrogens, permeation enhancers, and solvents from liquid formulations.
Pharmaceutical research 2002;19(5):661-8.
2002: Müller R H; Jacobs C
Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability.
International journal of pharmaceutics 2002;237(1-2):151-61.
2002: Olbrich Carsten; Kayser Oliver; Müller Rainer H
Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)--effect of surfactants, storage time and crystallinity.
International journal of pharmaceutics 2002;237(1-2):119-28.
2002: Lippacher A; Müller R H; Mäder K
Semisolid SLN dispersions for topical application: influence of formulation and production parameters on viscoelastic properties.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2002;53(2):155-60.
2002: Jacobs Claudia; Müller Rainer Helmut
Production and characterization of a budesonide nanosuspension for pulmonary administration.
Pharmaceutical research 2002;19(2):189-94.
2002: Harnisch S; Schuhmann R; Harnisch J F; Müller R H
Differences in the coalescence kinetics of fat emulsions in dependence on the amount of fat and age.
Die Pharmazie 2002;57(1):54-8.
2002: Rudolph C; Müller R H; Rosenecker J
Jet nebulization of PEI/DNA polyplexes: physical stability and in vitro gene delivery efficiency.
The journal of gene medicine 2002;4(1):66-74.
2002: Schöler N; Hahn H; Müller R H; Liesenfeld O
Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages.
International journal of pharmaceutics 2002;231(2):167-76.
2001: Olbrich C; Bakowsky U; Lehr C M; Müller R H; Kneuer C
Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA.
Journal of controlled release : official journal of the Controlled Release Society 2001;77(3):345-55.
2001: Wissing S A; Müller R H
Solid lipid nanoparticles (SLN)--a novel carrier for UV blockers.
Die Pharmazie 2001;56(10):783-6.
2001: Lind K; Kresse M; Müller R H
Comparison of protein adsorption patterns onto differently charged hydrophilic superparamagnetic iron oxide particles obtained in vitro and ex vivo.
Electrophoresis 2001;22(16):3514-21.
2001: Lindl K; Kresse M; Müller R H
Evaluation of desorption of proteins adsorbed to hydrophilic surfaces by two-dimensional electrophoresis.
Proteomics 2001;1(9):1059-66.
2001: Zimmermann E; Müller R H
Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle (SLN) dispersions in artificial gastrointestinal media.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2001;52(2):203-10.
2001: Wissing S A; Müller R H
A novel sunscreen system based on tocopherol acetate incorporated into solid lipid nanoparticles.
International journal of cosmetic science 2001;23(4):233-43.
2001: Krause K P; Müller R H
Production of aqueous shellac dispersions by high pressure homogenisation.
International journal of pharmaceutics 2001;223(1-2):89-92.
2001: Schöler N; Olbrich C; Tabatt K; Müller R H; Hahn H; Liesenfeld O
Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages.
International journal of pharmaceutics 2001;221(1-2):57-67.
2001: Schöler N; Krause K; Kayser O; Müller R H; Borner K; Hahn H; Liesenfeld O
Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis.
Antimicrobial agents and chemotherapy 2001;45(6):1771-9.
2001: Müller R H; Jacobs C; Kayser O
Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.
Advanced drug delivery reviews 2001;47(1):3-19.
2001: Gessner A; Olbrich C; Schröder W; Kayser O; Müller R H
The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles.
International journal of pharmaceutics 2001;214(1-2):87-91.
2001: Krause K P; Müller R H
Production and characterisation of highly concentrated nanosuspensions by high pressure homogenisation.
International journal of pharmaceutics 2001;214(1-2):21-4.
2001: Lippacher A; Müller R H; Mäder K
Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles.
International journal of pharmaceutics 2001;214(1-2):9-12.
2001: Jacobs C; Kayser O; Müller R H
Production and characterisation of mucoadhesive nanosuspensions for the formulation of bupravaquone.
International journal of pharmaceutics 2001;214(1-2):3-7.
2000: Thode K; Müller R H; Kresse M
Two-time window and multiangle photon correlation spectroscopy size and zeta potential analysis--highly sensitive rapid assay for dispersion stability.
Journal of pharmaceutical sciences 2000;89(10):1317-24.
2000: Schöler N; Zimmermann E; Katzfey U; Hahn H; Müller R H; Liesenfeld O
Effect of solid lipid nanoparticles (SLN) on cytokine production and the viability of murine peritoneal macrophages.
Journal of microencapsulation 2000;17(5):639-50.
2000: Rudolph C; Lausier J; Naundorf S; Müller R H; Rosenecker J
In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers.
The journal of gene medicine 2000;2(4):269-78.
2000: Gessner A; Paulke B R; Müller R H
Analysis of plasma protein adsorption onto polystyrene particles by two-dimensional electrophoresis: comparison of sample application and isoelectric focusing techniques.
Electrophoresis 2000;21(12):2438-42.
2000: Müller R H; Mäder K; Gohla S
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2000;50(1):161-77.
2000: Gessner A; Waicz R; Lieske A; Paulke B; Mäder K; Müller R H
Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption.
International journal of pharmaceutics 2000;196(2):245-9.
2000: Schöler N; Zimmermann E; Katzfey U; Hahn H; Müller R H; Liesenfeld O
Preserved solid lipid nanoparticles (SLN) at low concentrations do cause neither direct nor indirect cytotoxic effects in peritoneal macrophages.
International journal of pharmaceutics 2000;196(2):235-9.
2000: Seehof K; Kresse M; Mäder K; Müller R H
Interactions of nanoparticles with body proteins--improvement of 2D-PAGE-analysis by internal standard.
International journal of pharmaceutics 2000;196(2):231-4.
2000: Lippacher A; Müller R H; Mäder K
Investigation on the viscoelastic properties of lipid based colloidal drug carriers.
International journal of pharmaceutics 2000;196(2):227-30.
2000: Zimmermann E; Müller R H; Mäder K
Influence of different parameters on reconstitution of lyophilized SLN.
International journal of pharmaceutics 2000;196(2):211-3.
2000: Liedtke S; Wissing S; Müller R H; Mäder K
Influence of high pressure homogenisation equipment on nanodispersions characteristics.
International journal of pharmaceutics 2000;196(2):183-5.
2000: Krause K P; Kayser O; Mäder K; Gust R; Müller R H
Heavy metal contamination of nanosuspensions produced by high-pressure homogenisation.
International journal of pharmaceutics 2000;196(2):169-72.
2000: Jacobs C; Kayser O; Müller R H
Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide.
International journal of pharmaceutics 2000;196(2):161-4.
2000: Grau M J; Kayser O; Müller R H
Nanosuspensions of poorly soluble drugs--reproducibility of small scale production.
International journal of pharmaceutics 2000;196(2):155-9.
2000: Peters K; Leitzke S; Diederichs J E; Borner K; Hahn H; Müller R H; Ehlers S
Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection.
The Journal of antimicrobial chemotherapy 2000;45(1):77-83.
2000: Harnisch S; Müller R H
Adsorption kinetics of plasma proteins on oil-in-water emulsions for parenteral nutrition.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2000;49(1):41-6.
1999: Dingler A; Blum R P; Niehus H; Müller R H; Gohla S
Solid lipid nanoparticles (SLN/Lipopearls)--a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products.
Journal of microencapsulation 1999;16(6):751-67.
1999: Anger S; Caldwell K; Niehus H; Müller R H
High resolution size determination of 20 nm colloidal gold particles by SedFFF.
Pharmaceutical research 1999;16(11):1743-7.
1999: Lück M; Schröder W; Paulke B R; Blunk T; Müller R H
Complement activation by model drug carriers for intravenous application: determination by two-dimensional electrophoresis.
Biomaterials 1999;20(21):2063-8.
1999: Peters K; Müller R H; Craig D Q
An investigation into the distribution of lecithins in nanosuspension systems using low frequency dielectric spectroscopy.
International journal of pharmaceutics 1999;184(1):53-61.
1999: Freitas C; Müller R H
Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 1999;47(2):125-32.
1999: Olbrich C; Müller R H
Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures.
International journal of pharmaceutics 1999;180(1):31-9.
1999: Borner K; Hartwig H; Leitzke S; Hahn H; Müller R H; Ehlers S
HPLC determination of clofazimine in tissues and serum of mice after intravenous administration of nanocrystalline or liposomal formulations.
International journal of antimicrobial agents 1999;11(1):75-9.
1999: Freitas C; Müller R H
Stability determination of solid lipid nanoparticles (SLN) in aqueous dispersion after addition of electrolyte.
Journal of microencapsulation 1999;16(1):59-71.
1998: Lück M; Pistel K F; Li Y X; Blunk T; Müller R H; Kissel T
Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition.
Journal of controlled release : official journal of the Controlled Release Society 1998;55(2-3):107-20.
1998: Lück M; Paulke B R; Schröder W; Blunk T; Müller R H
Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics.
Journal of biomedical materials research 1998;39(3):478-85.
1998: Harnisch S; Müller R H
Plasma protein adsorption patterns on emulsions for parenteral administration: establishment of a protocol for two-dimensional polyacrylamide electrophoresis.
Electrophoresis 1998;19(2):349-54.
1998: Thode K; Lück M; Schröder W; Blunk T; Müller R H; Kresse M
The influence of the sample preparation on plasma protein adsorption patterns on polysaccharide-stabilized iron oxide particles and N-terminal microsequencing of unknown proteins.
Journal of drug targeting 1998;5(6):459-69.
1998: Bucke W E; Leitzke S; Diederichs J E; Borner K; Hahn H; Ehlers S; Müller R H
Surface-modified amikacin-liposomes: organ distribution and interaction with plasma proteins.
Journal of drug targeting 1998;5(2):99-108.
1997: Lück M; Schröder W; Harnisch S; Thode K; Blunk T; Paulke B R; Kresse M; Müller R H
Identification of plasma proteins facilitated by enrichment on particulate surfaces: analysis by two-dimensional electrophoresis and N-terminal microsequencing.
Electrophoresis 1997;18(15):2961-7.
1997: Thode K; Lück M; Semmler W; Müller R H; Kresse M
Determination of plasma protein adsorption on magnetic iron oxides: sample preparation.
Pharmaceutical research 1997;14(7):905-10.
1997: Müller R H; Rühl D; Runge S; Schulze-Forster K; Mehnert W
Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant.
Pharmaceutical research 1997;14(4):458-62.
1997: Müller R H; Rühl D; Lück M; Paulke B R
Influence of fluorescent labelling of polystyrene particles on phagocytic uptake, surface hydrophobicity, and plasma protein adsorption.
Pharmaceutical research 1997;14(1):18-24.
1997: Thode K; Lück M; Schröder W; Semmler W; Blunk T; Müller R H; Kresse M
The influence of the sample preparation on plasma protein adsorption patterns on polysaccharide-stabilized iron oxide particles and N-terminal microsequencing of unknown proteins.
Journal of drug targeting 1997;5(1):35-43.
1996: Hedeman H; Lück M; Blunk T; Frokjaer S; Müller R H
Fat emulsions based on structured lipids (1,3-specific triglycerides): an investigation of the in vitro interaction with plasma proteins.
Clinical nutrition (Edinburgh, Scotland) 1996;15(4):175-8.
1996: Müller R H; Maassen S; Weyhers H; Mehnert W
Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407.
Journal of drug targeting 1996;4(3):161-70.
1993: Blunk T; Hochstrasser D F; Sanchez J C; Müller B W; Müller R H
Colloidal carriers for intravenous drug targeting: plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis.
Electrophoresis 1993;14(12):1382-7.
1991: Müller R H; Heinemann S
Photon correlation spectroscopy and zeta potential characterization of model particles and colloidal drug carriers--essential information for the interpretation of cell culture studies.
Biochemical Society transactions 1991;19(2):502.
1984: Müller B W; Müller R H
Particle size distributions and particle size alterations in microemulsions.
Journal of pharmaceutical sciences 1984;73(7):919-22.
1984: Müller B W; Müller R H
Particle size analysis of latex suspensions and microemulsions by photon correlation spectroscopy.
Journal of pharmaceutical sciences 1984;73(7):915-8.

Sign-in to see more